In an initial small-scale clinical study, profiling of a mixed cohort of DN and ADPKD patients led to the identification of osteoprotegerin (OPG) in uEVs and its increased expression in patients with CKD compared to healthy controls (Benito-Martin et al., 2013). This evidence concerns the gene TNFRSF11B and liver dysplastic nodule.